Sensitivity analysis comparing characteristics of patients with completed and uncompleted questionnaires at 4 of the 6 completion times
| Time . | Age > 70 n (%) . | Males n (%) . | FEV1 < 70 n (%) . | DLCO < 70 n (%) . | CAD n (%) . | Diabetes n (%) . | Open surgery n (%) . | Stay >7 days n (%) . |
|---|---|---|---|---|---|---|---|---|
| Baseline | ||||||||
| Complete (91) | 33 (36) | 52 (57) | 17 (19) | 39 (43) | 13 (14) | 8 (8.8) | 11 (12) | 14 (15) |
| No test (12) | 1 (8.3) | 5 (42) | 3 (25) | 8 (67) | 1 (8.3) | 1 (8.3) | 5 (42) | 0 (0) |
| P-values | 0.098 | 0.36 | 0.69 | 0.14 | 1.00 | 1.00 | 0.020 | 0.36 |
| POD1 | ||||||||
| Complete (93) | 33 (35) | 54 (58) | 19 (20) | 41 (44) | 9 (9.6) | 7 (7.5) | 13 (14) | 14 (15) |
| No test (10) | 1 (10) | 3 (30) | 1 (10) | 6 (60) | 0 (0) | 2 (20) | 3 (30) | 0 (0) |
| P-values | 0.16 | 0.11 | 0.68 | 0.51 | 0.59 | 0.21 | 0.19 | 0.35 |
| POD14 | ||||||||
| Complete (85) | 26 (31) | 47 (55) | 19 (22) | 40 (47) | 9 (11) | 6 (7.1) | 14 (17) | 13 (15) |
| No test (18) | 8 (44) | 10 (56) | 1 (5.5) | 7 (39) | 0 (0) | 3 (17) | 2 (11) | 1 (5.5) |
| P-values | 0.28 | 1.00 | 0.19 | 0.61 | 0.35 | 0.19 | 0.72 | 0.45 |
| 1 month | ||||||||
| Complete (58) | 19 (33) | 33 (57) | 13 (22) | 27 (47) | 5 (8.6) | 4 (6.9) | 10 (17) | 9 (16) |
| No test (45) | 15 (33) | 24 (53) | 7 (16) | 20 (44) | 4 (8.8) | 5 (11) | 6 (13) | 5 (11) |
| P-values | 1.00 | 0.84 | 0.46 | 0.85 | 1.00 | 0.50 | 0.79 | 0.58 |
| Time . | Age > 70 n (%) . | Males n (%) . | FEV1 < 70 n (%) . | DLCO < 70 n (%) . | CAD n (%) . | Diabetes n (%) . | Open surgery n (%) . | Stay >7 days n (%) . |
|---|---|---|---|---|---|---|---|---|
| Baseline | ||||||||
| Complete (91) | 33 (36) | 52 (57) | 17 (19) | 39 (43) | 13 (14) | 8 (8.8) | 11 (12) | 14 (15) |
| No test (12) | 1 (8.3) | 5 (42) | 3 (25) | 8 (67) | 1 (8.3) | 1 (8.3) | 5 (42) | 0 (0) |
| P-values | 0.098 | 0.36 | 0.69 | 0.14 | 1.00 | 1.00 | 0.020 | 0.36 |
| POD1 | ||||||||
| Complete (93) | 33 (35) | 54 (58) | 19 (20) | 41 (44) | 9 (9.6) | 7 (7.5) | 13 (14) | 14 (15) |
| No test (10) | 1 (10) | 3 (30) | 1 (10) | 6 (60) | 0 (0) | 2 (20) | 3 (30) | 0 (0) |
| P-values | 0.16 | 0.11 | 0.68 | 0.51 | 0.59 | 0.21 | 0.19 | 0.35 |
| POD14 | ||||||||
| Complete (85) | 26 (31) | 47 (55) | 19 (22) | 40 (47) | 9 (11) | 6 (7.1) | 14 (17) | 13 (15) |
| No test (18) | 8 (44) | 10 (56) | 1 (5.5) | 7 (39) | 0 (0) | 3 (17) | 2 (11) | 1 (5.5) |
| P-values | 0.28 | 1.00 | 0.19 | 0.61 | 0.35 | 0.19 | 0.72 | 0.45 |
| 1 month | ||||||||
| Complete (58) | 19 (33) | 33 (57) | 13 (22) | 27 (47) | 5 (8.6) | 4 (6.9) | 10 (17) | 9 (16) |
| No test (45) | 15 (33) | 24 (53) | 7 (16) | 20 (44) | 4 (8.8) | 5 (11) | 6 (13) | 5 (11) |
| P-values | 1.00 | 0.84 | 0.46 | 0.85 | 1.00 | 0.50 | 0.79 | 0.58 |
Results are expressed as counts. POD7 and POD21 not shown (Fisher’s exact test).
CAD: coronary artery disease; DLCO: carbon monoxide lung diffusion capacity; FEV1: forced expiratory volume in 1 s; POD: postoperative day.
Sensitivity analysis comparing characteristics of patients with completed and uncompleted questionnaires at 4 of the 6 completion times
| Time . | Age > 70 n (%) . | Males n (%) . | FEV1 < 70 n (%) . | DLCO < 70 n (%) . | CAD n (%) . | Diabetes n (%) . | Open surgery n (%) . | Stay >7 days n (%) . |
|---|---|---|---|---|---|---|---|---|
| Baseline | ||||||||
| Complete (91) | 33 (36) | 52 (57) | 17 (19) | 39 (43) | 13 (14) | 8 (8.8) | 11 (12) | 14 (15) |
| No test (12) | 1 (8.3) | 5 (42) | 3 (25) | 8 (67) | 1 (8.3) | 1 (8.3) | 5 (42) | 0 (0) |
| P-values | 0.098 | 0.36 | 0.69 | 0.14 | 1.00 | 1.00 | 0.020 | 0.36 |
| POD1 | ||||||||
| Complete (93) | 33 (35) | 54 (58) | 19 (20) | 41 (44) | 9 (9.6) | 7 (7.5) | 13 (14) | 14 (15) |
| No test (10) | 1 (10) | 3 (30) | 1 (10) | 6 (60) | 0 (0) | 2 (20) | 3 (30) | 0 (0) |
| P-values | 0.16 | 0.11 | 0.68 | 0.51 | 0.59 | 0.21 | 0.19 | 0.35 |
| POD14 | ||||||||
| Complete (85) | 26 (31) | 47 (55) | 19 (22) | 40 (47) | 9 (11) | 6 (7.1) | 14 (17) | 13 (15) |
| No test (18) | 8 (44) | 10 (56) | 1 (5.5) | 7 (39) | 0 (0) | 3 (17) | 2 (11) | 1 (5.5) |
| P-values | 0.28 | 1.00 | 0.19 | 0.61 | 0.35 | 0.19 | 0.72 | 0.45 |
| 1 month | ||||||||
| Complete (58) | 19 (33) | 33 (57) | 13 (22) | 27 (47) | 5 (8.6) | 4 (6.9) | 10 (17) | 9 (16) |
| No test (45) | 15 (33) | 24 (53) | 7 (16) | 20 (44) | 4 (8.8) | 5 (11) | 6 (13) | 5 (11) |
| P-values | 1.00 | 0.84 | 0.46 | 0.85 | 1.00 | 0.50 | 0.79 | 0.58 |
| Time . | Age > 70 n (%) . | Males n (%) . | FEV1 < 70 n (%) . | DLCO < 70 n (%) . | CAD n (%) . | Diabetes n (%) . | Open surgery n (%) . | Stay >7 days n (%) . |
|---|---|---|---|---|---|---|---|---|
| Baseline | ||||||||
| Complete (91) | 33 (36) | 52 (57) | 17 (19) | 39 (43) | 13 (14) | 8 (8.8) | 11 (12) | 14 (15) |
| No test (12) | 1 (8.3) | 5 (42) | 3 (25) | 8 (67) | 1 (8.3) | 1 (8.3) | 5 (42) | 0 (0) |
| P-values | 0.098 | 0.36 | 0.69 | 0.14 | 1.00 | 1.00 | 0.020 | 0.36 |
| POD1 | ||||||||
| Complete (93) | 33 (35) | 54 (58) | 19 (20) | 41 (44) | 9 (9.6) | 7 (7.5) | 13 (14) | 14 (15) |
| No test (10) | 1 (10) | 3 (30) | 1 (10) | 6 (60) | 0 (0) | 2 (20) | 3 (30) | 0 (0) |
| P-values | 0.16 | 0.11 | 0.68 | 0.51 | 0.59 | 0.21 | 0.19 | 0.35 |
| POD14 | ||||||||
| Complete (85) | 26 (31) | 47 (55) | 19 (22) | 40 (47) | 9 (11) | 6 (7.1) | 14 (17) | 13 (15) |
| No test (18) | 8 (44) | 10 (56) | 1 (5.5) | 7 (39) | 0 (0) | 3 (17) | 2 (11) | 1 (5.5) |
| P-values | 0.28 | 1.00 | 0.19 | 0.61 | 0.35 | 0.19 | 0.72 | 0.45 |
| 1 month | ||||||||
| Complete (58) | 19 (33) | 33 (57) | 13 (22) | 27 (47) | 5 (8.6) | 4 (6.9) | 10 (17) | 9 (16) |
| No test (45) | 15 (33) | 24 (53) | 7 (16) | 20 (44) | 4 (8.8) | 5 (11) | 6 (13) | 5 (11) |
| P-values | 1.00 | 0.84 | 0.46 | 0.85 | 1.00 | 0.50 | 0.79 | 0.58 |
Results are expressed as counts. POD7 and POD21 not shown (Fisher’s exact test).
CAD: coronary artery disease; DLCO: carbon monoxide lung diffusion capacity; FEV1: forced expiratory volume in 1 s; POD: postoperative day.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
